Aziz B, Kok B, Cheah M, Lytvyak E, Moctezuma-Velazquez C, Wasilenko S
Am J Gastroenterol. 2025; 120(2):459-468.
PMID: 39888688
PMC: 11774198.
DOI: 10.14309/ajg.0000000000002977.
Fu H, Dong J, Sun Z, Zhang X, Yu A, Chen G
Ann Transl Med. 2020; 8(10):648.
PMID: 32566585
PMC: 7290620.
DOI: 10.21037/atm-20-3074.
Liu D, Ndongwe T, Puray-Chavez M, Casey M, Izumi T, Pathak V
FASEB J. 2020; 34(7):9433-9449.
PMID: 32496609
PMC: 8214447.
DOI: 10.1096/fj.201800641R.
Ghany M, Morgan T
Hepatology. 2019; 71(2):686-721.
PMID: 31816111
PMC: 9710295.
DOI: 10.1002/hep.31060.
Bhatt A, Everson G
Clin Liver Dis (Hoboken). 2019; 2(Suppl 5):73-77.
PMID: 31333829
PMC: 6448671.
DOI: 10.1002/cld.278.
Hepatitis C viral infection after liver transplantation.
Verna E, Brown Jr R
Clin Liver Dis (Hoboken). 2019; 1(3):73-76.
PMID: 31186853
PMC: 6499271.
DOI: 10.1002/cld.62.
Hepatitis C virus: Management of recurrent disease.
Verna E
Clin Liver Dis (Hoboken). 2019; 2(4):177-180.
PMID: 30992857
PMC: 6448642.
DOI: 10.1002/cld.220.
Hepatitis C virus: Antiviral therapy in wait-listed patients.
Bhatt A, Everson G
Clin Liver Dis (Hoboken). 2019; 2(4):173-176.
PMID: 30992856
PMC: 6448647.
DOI: 10.1002/cld.225.
Assessment of hepatitis C risk factors in center of Iran: A case-control study.
Shahriari-Fard F, Alavian S, Farajzadegan Z, Rabiei A, Ataei B, Ataie M
J Res Med Sci. 2018; 23:87.
PMID: 30505325
PMC: 6225444.
DOI: 10.4103/jrms.JRMS_1211_17.
The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation.
Albekairy A, Abdel-Razaq W, Alkatheri A, Debasi T, Otaibi N, Qandil A
Int J Health Sci (Qassim). 2018; 12(4):78-87.
PMID: 30022908
PMC: 6040860.
Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort.
Bernuth S, Grimm D, Vollmar J, Darstein F, Mittler J, Heise M
Drug Des Devel Ther. 2017; 11:2131-2138.
PMID: 28744104
PMC: 5513830.
DOI: 10.2147/DDDT.S139837.
Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation.
Hori T, Onishi Y, Kamei H, Kurata N, Ishigami M, Ishizu Y
Ann Gastroenterol. 2016; 29(4):454-459.
PMID: 27708510
PMC: 5049551.
DOI: 10.20524/aog.2016.0069.
Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report.
Seifert L, Heinzow H, Kabar I, Christensen S, Husing A, Schmidt H
Am J Case Rep. 2016; 17:605-10.
PMID: 27554644
PMC: 4999016.
DOI: 10.12659/ajcr.895839.
Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic Dilemma.
Hori T, Onishi Y, Kamei H, Kurata N, Ishigami M, Ishizu Y
Am J Case Rep. 2016; 17:597-604.
PMID: 27545580
PMC: 4994933.
DOI: 10.12659/ajcr.898427.
Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series.
Torres H, Kaseb A, Mahale P, Miller E, Frenette C
J Hepatocell Carcinoma. 2016; 1:109-14.
PMID: 27508180
PMC: 4918269.
DOI: 10.2147/JHC.S60867.
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song A, Sobesky R, Vinaixa C, Dumortier J, Radenne S, Durand F
World J Gastroenterol. 2016; 22(18):4547-58.
PMID: 27182164
PMC: 4858636.
DOI: 10.3748/wjg.v22.i18.4547.
Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis.
Nguyen N, Yee B, Chang C, Jin M, Lutchman G, Lim J
BMJ Open Gastroenterol. 2016; 3(1):e000066.
PMID: 26966549
PMC: 4782279.
DOI: 10.1136/bmjgast-2015-000066.
Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management.
Mitchell O, Cosar A, Malik M, Gurakar A
Hepatol Int. 2015; 10(1):106-14.
PMID: 26603541
DOI: 10.1007/s12072-015-9685-2.
The Correlation of Hepatic and Systemic Hemodynamics During Liver Transplantation: Quantification of Hepatic Resistance as an Actual Value.
Feng A, Chen T, Fan H, Yu J, Hsieh C
Medicine (Baltimore). 2015; 94(43):e1815.
PMID: 26512581
PMC: 4985395.
DOI: 10.1097/MD.0000000000001815.
Impact of new treatment options for hepatitis C virus infection in liver transplantation.
Righi E, Londero A, Carnelutti A, Baccarani U, Bassetti M
World J Gastroenterol. 2015; 21(38):10760-75.
PMID: 26478668
PMC: 4600578.
DOI: 10.3748/wjg.v21.i38.10760.
